Skip to main content Skip to main navigation menu Skip to site footer
Bleeding, Thrombosis and Vascular Biology

Editor-in-Chief: Giovanni de Gaetano, Italy | eISSN: 2785-5309

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Copyright
  • Special Issues
    • Overview
  • Register
  • Login
  • Search
  • Contacts
  • News
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Long-term persistence of high anti-PF4 antibodies titer in a challenging case of AZD1222 vaccine-induced thrombotic thrombocytopenia

    Luca Barcella, Chiara Ambaglio, Paolo Gritti, Francesca Schieppati, Varusca Brusegan, Eleonora Sanga, Marina Marchetti, Luca Lorini, Anna Falanga
    28-06-2023
    https://doi.org/10.4081/btvb.2023.72
    565
    PDF: 189
  • Vaccine-induced immune thrombotic thrombocytopenia following ChAdOx1 nCoV-19 vaccine: report of two cases

    Rita Carlotta Santoro, Roberto Minici, Marzia Leotta, Mariapia Falbo, Lucia Concetta Elia, Francesca Leo, Antonella Ierardi, Alessandra Strangio, Simona Prejanò
    23-05-2022
    https://doi.org/10.4081/btvb.2022.23
    3725
    PDF: 262
  • Thrombin generation assay in COVID-19 patients shows a hypocoagulable pattern

    Giovanni L. Tiscia, Donatella Colaizzo, Antonio De Laurenzo, Filomena Cappucci, Lucia Fischetti, Elena Chinni, Mario Mastroianno, Giovanni Favuzzi, Massimo Carella, Elvira Grandone
    22-10-2024
    https://doi.org/10.4081/btvb.2024.145
    1833
    PDF: 261
    Supplementary: 185
  • Attitude to clinical research among health professionals affiliated with the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA)

    Daniela Poli, Riccardo Tartaglia, Doris Barcellona , Paolo Bucciarelli , Antonio Ciampa, Elvira Grandone, Giuseppe Malcangi, Giuseppe Rescigno, Vincenzo Toschi, Sophie Testa, Alessandro Squizzato
    21-03-2023
    https://doi.org/10.4081/btvb.2023.59
    542
    PDF: 222
  • Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma

    Yishi Tan, Marc Carrier, Nicola Curry, Michael Desborough, Kathryn Musgrave, Marie Scully, Tzu-Fei Wang, Mari Thomas, Simon J. Stanworth
    16-05-2024
    https://doi.org/10.4081/btvb.2024.115
    665
    PDF: 209
  • https://pixabay.com/users/geralt-9301/?utm_source=link-attribution&utm_medium=referral&utm_campaign=image&utm_content=1571860

    Artificial intelligence and machine learning in hemostasis and thrombosis

    Paolo Gresele
    30-12-2023
    https://doi.org/10.4081/btvb.2023.105
    2365
    PDF: 478
  • Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)

    Daniela Poli, Walter Ageno, Emilia Antonucci, Salvatore Bradamante, Eugenio Bucherini, Paolo Chiarugi, Antonio Chistolini, Benilde Cosmi, Anna Falanga, Antonio Insana, Domenico Lione, Rosa Maria Lombardi, Giuseppe Malcangi, Rossella Marcucci, Giuliana Martini, Lucilla Masciocco, Carmelo Paparo, Daniele Pastori, Simona Pedrini, Vittorio Pengo, Pasquale Pignatelli, Andrea Toma, Sophie Testa, Gualtiero Palareti
    27-06-2023
    https://doi.org/10.4081/btvb.2023.84
    1231
    PDF: 280
    Supplementary File: 151
  • Allopurinol-induced acquired von Willebrand syndrome

    Juan Eirís, Marina Suárez-Terrón, Pablo Granados, David Martínez-Campuzano, Ana Rosa Cid, Saturnino Haya, Santiago Bonanad
    25-10-2023
    https://doi.org/10.4081/btvb.2023.88
    1581
    PDF: 185
  • Pathways for lower extremity superficial vein thrombosis management in an academic medical center

    Gisoo Imani, Aaron Wilson, Sara Vazquez, Daniel M. Witt
    24-03-2025
    https://doi.org/10.4081/btvb.2025.155
    172
    PDF: 36
  • Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries

    Vittorio Pengo, Luca Sarti, Emilia Antonucci, Stefania Di Agostino, Elisa Bison, Gentian Denas, Daniela Poli, Pier Luigi Meroni, Roberto Gerli, Antonella Radice, Gualtiero Palareti, on behalf of FIRMA group and START collaborators
    12-10-2023
    https://doi.org/10.4081/btvb.2023.92
    777
    PDF: 219
  • A commitment to global collaboration, welcoming international participation and advancing science for the benefit of patients

    Pantep Angchaisuksiri, Wolfram Ruf, Jeffrey Weitz, Sam Schulman, Guy A. Young
    18-04-2025
    https://doi.org/10.4081/btvb.2025.188
    144
    PDF: 38
  • Successful treatment of aortic arch mural thrombosis with low-dose, ultra-slow-flow thrombolysis: a case report and literature review

    Rosina Albisinni, Tommaso Marrazzo, Arta Karruli, Sabrina Manduca, Giuseppe Nobile, Nicola Galdieri, Marisa De Feo
    24-10-2022
    https://doi.org/10.4081/btvb.2022.44
    557
    PDF: 180
  • Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history

    Paolo Simioni, Vittorio Pengo, Paolo Prandoni
    07-11-2022
    https://doi.org/10.4081/btvb.2022.52
    1983
    PDF: 219
  • Stroke in women: anticoagulation in a complicated puzzle

    Francesco Marongiu, Elvira Grandone, Silvia Marongiu, Antonella Mameli, Doris Barcellona
    26-08-2024
    https://doi.org/10.4081/btvb.2024.137
    1074
    PDF: 283
  • The use of creatine and the development of deep vein thrombosis. A scoping review

    Kartik Akkihal, Thomas Varkey, James Kelbert
    18-11-2024
    https://doi.org/10.4081/btvb.2024.142
    2804
    PDF: 252
    Supplementary: 97
  • Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis

    Maria J. Fernandez Turizo, Rushad Patell, Jeffrey I. Zwicker
    16-05-2024
    https://doi.org/10.4081/btvb.2024.120
    719
    PDF: 310
  • Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia

    Bianca Clerici, Mariangela Scavone, Gian Marco Podda
    20-06-2024
    https://doi.org/10.4081/btvb.2024.127
    1879
    PDF: 507
  • From rare to aware: confronting Lemierre syndrome

    Silvia Cardi, Filippo Catalani, Luca Valerio, Stefano Barco
    21-10-2024
    https://doi.org/10.4081/btvb.2024.147
    1709
    PDF: 350
  • Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

    Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli
    22-03-2022
    https://doi.org/10.4081/btvb.2022.10
    1045
    PDF: 330
    APPENDIX: 67
  • Is non-alcoholic fatty liver disease a prothrombotic risk factor?

    Niccolò Bitto, Vincenzo La Mura, Anna Ludovica Fracanzani, Armando Tripodi
    19-05-2023
    https://doi.org/10.4081/btvb.2023.81
    595
    PDF: 190
  • Diagnosis and management of abnormal uterine bleeding in adolescence An expert Consensus Statement of SIGO (Italian Society of Gynecology and Obstetrics) and SISET (Italian Society for the Study of Hemostasis and Thrombosis)

    Roberto Mario Santi, Annamaria Fulghesu, Ezio Zanon, Erica De Candia, Elvira Grandone, Giancarlo Di Renzo, Claudia Succu, Valentina Tosto, Vincenzina Bruni, Paolo Gresele
    08-05-2024
    https://doi.org/10.4081/btvb.2024.106
    821
    PDF: 323
  • Distal deep vein thrombosis: is there a way out of this dark forest?

    Matteo Guarascio, Gerardo Nicola Pititto, Alessia Abenante, Marco Paolo Donadini
    04-09-2024
    https://doi.org/10.4081/btvb.2024.129
    696
    PDF: 219
  • New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis

    Mehrie H. Patel, Alok A. Khorana
    16-05-2024
    https://doi.org/10.4081/btvb.2024.113
    502
    PDF: 236
  • Clinical and radiological characteristics of cerebral vein thrombosis: a retrospective study

    Mosaad Almegren
    12-10-2023
    https://doi.org/10.4081/btvb.2023.85
    318
    PDF: 147
  • Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

    Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz
    16-05-2024
    https://doi.org/10.4081/btvb.2024.118
    772
    PDF: 301
  • Welcome to the 12th International Conference on Thrombosis and Hemostasis Issues in Cancer! Proceedings

    Anna Falanga, Benjamin Brenner, Alok A. Khorana
    16-05-2024
    https://doi.org/10.4081/btvb.2024.138
    1396
    PDF: 252
  • The introduction of the international normalized ratio as a breakthrough event in the history of thrombosis

    Armando Tripodi
    23-01-2025
    https://doi.org/10.4081/btvb.2025.169
    636
    PDF: 211
  • Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review

    Ang Li, Emily Zhou
    16-05-2024
    https://doi.org/10.4081/btvb.2024.108
    693
    PDF: 266
  • Patient and public involvement in cancer-associated thrombosis research: necessary or glorified tokenism?

    Simon Noble
    16-05-2024
    https://doi.org/10.4081/btvb.2024.125
    1167
    PDF: 182
  • Artificial intelligence, platelets and aspirin

    Giovanni de Gaetano
    15-03-2024
    https://doi.org/10.4081/btvb.2024.130
    391
    PDF: 178
  • Evaluation of Coaguchek®Pro II coagulation testing device performance to assess direct oral anticoagulant action. The DOAC-CHECK study

    Cristina Legnani, Michela Cini, Sophie Testa, Alberto Tosetto, Claudia Dellanoce, Stefania Bellesso, Giuseppe Carli, Ilaria Nichele, Laura Lissandrini, Serena Zorzi, Emilia Antonucci, Gualtiero Palareti
    01-12-2022
    https://doi.org/10.4081/btvb.2022.37
    1452
    PDF: 291
  • At the age of three

    Giovanni de Gaetano, Chiara Cerletti
    16-12-2024
    https://doi.org/10.4081/btvb.2024.166
    267
    PDF: 77
  • Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot

    Rushad Patell, Jeffrey I. Zwicker, Rohan Singh, Simon Mantha
    16-05-2024
    https://doi.org/10.4081/btvb.2024.123
    1283
    PDF: 294
  • Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life

    Ilaria Nichele, Giuseppe Carli, Alberto Tosetto
    22-04-2024
    https://doi.org/10.4081/btvb.2024.104
    409
    PDF: 131
  • Remembering the XXVI SISET Congress and the 50th anniversary of its foundation, 2020

    Armando Tripodi
    17-01-2025
    https://doi.org/10.4081/btvb.2025.171
    1023
    PDF: 193
  • New perspectives for prevention of the post-thrombotic syndrome

    Paolo Prandoni
    22-03-2022
    https://doi.org/10.4081/btvb.2022.20
    1450
    PDF: 441
  • SISET50: trajectories of hemostasis and thrombosis in Italy 1970-2020

    Giovanni de Gaetano, Maria Benedetta Donati, Americo Bonanni
    17-01-2025
    https://doi.org/10.4081/btvb.2025.170
    950
    PDF: 199
  • Coagulome and tumor microenvironment: impact of oncogenes, cellular heterogeneity and extracellular vesicles

    Nadim Tawil, Lata Adnani, Janusz Rak
    16-05-2024
    https://doi.org/10.4081/btvb.2024.109
    404
    PDF: 159
  • How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

    Anna Falanga, Hugo Ten Cate, Bianca Rocca
    27-01-2023
    https://doi.org/10.4081/btvb.2023.60
    657
    PDF: 298
  • Comments on “Safe and effective anticoagulation use: case studies in anticoagulation stewardship”

    Marco Marietta, Giancarlo Castaman
    27-05-2025
    https://doi.org/10.4081/btvb.2025.180
    324
    PDF: 114
  • A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice

    Stefania Momi, Giuseppe Guglielmini, Giulia Ciarroca Taranta, Elisa Giglio, Angela Monopoli, Paolo Gresele
    23-05-2022
    https://doi.org/10.4081/btvb.2022.19
    4642
    PDF: 263
  • Role of platelet autophagy in cardiovascular diseases

    Luca D'Ambrosio, Maurizio Forte, Giacomo Frati, Sebastiano Sciarretta
    26-08-2024
    https://doi.org/10.4081/btvb.2024.133
    840
    PDF: 224
  • Talking about assisted reproductive techniques and thromboembolic risk: everything we always wanted to know

    Giovanni Tiscia, Elvira Grandone
    13-09-2022
    https://doi.org/10.4081/btvb.2022.43
    2188
    PDF: 252
  • Well begun is half done

    Giovanni de Gaetano
    14-12-2022
    https://doi.org/10.4081/btvb.2022.61
    1532
    PDF: 158
  • Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

    Marco P. Donadini, Walter Ageno
    15-04-2022
    https://doi.org/10.4081/btvb.2022.22
    2007
    PDF: 528
  • Clonal hematopoiesis and inflammation: a link with thrombosis and malignancy

    Tiziano Barbui
    21-07-2022
    https://doi.org/10.4081/btvb.2022.38
    2884
    PDF: 303
  • Antithrombotic therapy in idiopathic infertility

    Fabio Tumminello, Silvia Cardi, Corrado Lodigiani, Maria Elisa Mancuso
    03-10-2024
    https://doi.org/10.4081/btvb.2024.126
    1909
    PDF: 434
  • What is the gender of thrombosis? A natural model of precision medicine

    Rossella Marcucci, Rosanna Abbate
    03-08-2023
    https://doi.org/10.4081/btvb.2023.87
    480
    PDF: 172
  • Welcome to AICE and sincere wishes for peace for the new year 2024

    Giovanni de Gaetano
    27-12-2023
    https://doi.org/10.4081/btvb.2023.107
    1241
    PDF: 126
  • Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

    Agnes Y.Y. Lee
    29-02-2024
    https://doi.org/10.4081/btvb.2024.111
    1449
    PDF: 307
  • Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study

    Daniela Poli, Emilia Antonucci, Gualtiero Palareti, Roberto Facchinetti, Pietro Falco, Giuseppina Serricchio, Teresa Lerede, Lucilla Masciocco, Paolo Gresele, Sophie Testa
    27-07-2022
    https://doi.org/10.4081/btvb.2022.34
    4574
    PDF: 387
    Supplementary Files: 114
  • The balance between hemorrhage and thrombosis in patients surviving spontaneous intracerebral bleeding: the nightmare of a neurologist

    Alessandro Pezzini
    21-08-2024
    https://doi.org/10.4081/btvb.2024.151
    1277
    PDF: 340
  • Welcome to the 12th International Conference on Thrombosis and Hemostasis Issues in Cancer! Oral Communications and Posters

    Anna Falanga, Benjamin Brenner, Alok A. Khorana
    16-05-2024
    https://doi.org/10.4081/btvb.2024.139
    410
    PDF: 344
  • Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry

    Paolo Prandoni, Franca Bilora, Raffaele Pesavento, Giorgina Salgueiro, Angeles Blanco-Molina, Raquel Lòpez-Reyes, Manuel Monreal, and the RIETE Investigators
    23-05-2022
    https://doi.org/10.4081/btvb.2022.28
    5192
    PDF: 448
    APPENDIX: 118
  • Thrombotic thrombocytopenic purpura: much done, but still a lot to do

    Paola Binetti
    29-08-2024
    https://doi.org/10.4081/btvb.2024.149
    497
    PDF: 170
  • Addressing some challenges of congenital fibrinogen disorders in 2023 and beyond

    Cristina Santoro, Alessandro Casini
    03-08-2023
    https://doi.org/10.4081/btvb.2023.75
    1107
    PDF: 267
  • Polycythemia vera and management of the thrombotic risk: an update

    Massimo Franchini
    20-12-2023
    https://doi.org/10.4081/btvb.2023.102
    1851
    PDF: 273
  • The von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis

    Stefano Lancellotti, Monica Sacco, Maira Tardugno, Antonietta Ferretti, Raimondo De Cristofaro
    26-04-2022
    https://doi.org/10.4081/btvb.2022.11
    1995
    PDF: 347
  • The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

    Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno
    04-09-2024
    https://doi.org/10.4081/btvb.2024.144
    858
    PDF: 197
    SUPPLEMENTARY MATERIAL: 92
  • Endothelial cell dysfunction in cancer: a not-so-innocent bystander

    Betül Ünlü, Neha Joshi, Jamie M. O'Sullivan
    16-05-2024
    https://doi.org/10.4081/btvb.2024.116
    1245
    PDF: 237
  • Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series

    Luca Puccetti, Vincenzo Sammartano, Federico Caroni, Margherita Malchiodi, Paola Calzoni, Eleonora Franceschini, Lucrezia Galasso, Monica Bocchia
    17-10-2022
    https://doi.org/10.4081/btvb.2022.40
    2386
    PDF: 223
  • The importance of rigorous and engaging scientific communication

    Giovanni de Gaetano
    14-05-2025
    https://doi.org/10.4081/btvb.2025.191
    157
    PDF: 64
  • Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy

    Gary E. Raskob
    16-05-2024
    https://doi.org/10.4081/btvb.2024.124
    546
    PDF: 216
  • A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma

    Vincenzo Sammartano, Adele Santoni, Elisabetta Zappone, Paola Calzoni, Daniela Fineschi, Eleonora Franceschini, Federico Caroni, Anna Sicuranza, Monica Bocchia, Luca Puccetti
    09-03-2023
    https://doi.org/10.4081/btvb.2023.53
    678
    PDF: 348
  • Gene transfer in hemophilia A: not cogent yet

    Pier Mannuccio Mannucci
    20-04-2022
    https://doi.org/10.4081/btvb.2022.32
    2027
    PDF: 231
  • The new era of anticoagulation: factor XI and XII inhibitors

    Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol
    07-06-2023
    https://doi.org/10.4081/btvb.2023.76
    2132
    PDF: 856
  • Location of metastasis and complications in patients with venous thromboembolism and cancer: a systematic review

    Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares
    16-05-2024
    https://doi.org/10.4081/btvb.2024.114
    483
    PDF: 179
  • Venous thromboembolism prophylaxis in orthopedic surgery: a narrative review

    Sarah Gallitto, Thomas C. Varkey, Jacob Lahti
    13-12-2024
    https://doi.org/10.4081/btvb.2024.131
    1077
    PDF: 175
  • Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?

    Mattia Galli, C. Michael Gibson, Dominick J. Angiolillo
    03-08-2023
    https://doi.org/10.4081/btvb.2023.90
    1362
    PDF: 454
  • Author's Reply. Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial

    Giovanni de Gaetano
    05-12-2024
    https://doi.org/10.4081/btvb.2024.163
    537
    PDF: 109
  • Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled trial"

    Vittorio Pengo
    16-04-2025
    https://doi.org/10.4081/btvb.2025.179
    159
    PDF: 44
  • 28th SISET National Congress | Rome, Italy, 6-9 November 2024

    Società Italiana per lo Studio dell'Emostasi e Trombosi – SISET
    06-11-2024
    https://doi.org/10.4081/btvb.2024.160
    1918
    PDF: 391
  • An ecological alliance against air pollution and cardiovascular disease

    Pier Mannuccio Mannucci
    22-03-2022
    https://doi.org/10.4081/btvb.2022.21
    1735
    PDF: 279
  • Growing weapons to fight hemophilia

    Pier Mannuccio Mannucci
    23-02-2023
    https://doi.org/10.4081/btvb.2023.64
    754
    PDF: 307
  • Venous thromboembolism and mortality in patients with hematological malignancies

    Kristen M. Sanfilippo, Tzu-Fei Wang
    16-05-2024
    https://doi.org/10.4081/btvb.2024.119
    660
    PDF: 233
  • A re-appraisal of thrombogenesis in COVID-19, seen as a multiple "Complex system"

    Sergio Coccheri
    24-10-2022
    https://doi.org/10.4081/btvb.2022.48
    1668
    PDF: 266
  • The 2024 Nobel prize in Medicine: impact on hemostasis and thrombosis research

    Loredana Bury, Marco Malvestiti, Paolo Gresele
    19-11-2024
    https://doi.org/10.4081/btvb.2024.159
    919
    PDF: 216
  • The clinical usefulness of measuring thrombin generation

    Coenraad H. Hemker
    06-03-2023
    https://doi.org/10.4081/btvb.2023.62
    812
    PDF: 361
1 - 78 of 78 items

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a scientific paper
  • How to write a Review article

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to review

Categories

    • Contents
    • Original Articles
    • Reviews
    • Editorials
    • Case Reports
    • Letters
    • Correspondence
    • Abstract Book
    • Remembrances

indexing

INDEXING
  • DOAJ
  • Google Scholar
  • OpenAlex
  • Analytics

aice

Affiliated Scientific Society

Vol. 4 No. 2 (2025)
A commitment to global collaboration, welcoming international participation and advancing science for the benefit of patients
Pantep Angchaisuksiri et al.
18 April 2025
Vol. 4 No. 2 (2025)
2024 EACTS guidelines on perioperative medication in adult cardiac surgery: embracing precision medicine driven by strong evidence-based methodology
Bianca Rocca et al.
16 April 2025
Vol. 4 No. 2 (2025)
Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or...
Vittorio Pengo
16 April 2025

Keywords

Bleeding, Thrombosis and Vascular Biology

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

eISSN: 2785-5309

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

Themes by Openjournaltheme.com

© PAGEPress 2008-2025    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy